Demonstrating continued and sustained impact for people in low- and middle-income countries (LMICs), MPP today publishes its 2025 annual report, From Innovation to Access. 👉 Download MPP's 2025 Annual Report: medicinespatentpool.org/news-publica...

💡 Did you know? #MedsPaL is a free resource providing crucial information on the intellectual property status of patented essential medicines in LMICs, patent information on COVID-19 and Mpox vaccines, and long-acting platform technologies worldwide. 👉 www.medspal.org

At #ASCO26, the conversation is rightly focused on #innovation. @medicinespatentpool.org is a partner of choice to explore how innovation can reach patients in LMICs in a sustainable way while generating #value for patent holders.

Trump fired the head of the Office of Government Ethics.. Well over a year later, he has yet to nominate a replacement. The White House isn’t answering questions. This administration doesn’t give a damn about ethics or accountability to the American people.

At #WHA79, MPP welcomed the renewed commitment to accelerate progress towards malaria elimination. Public health-oriented #voluntarylicensing helps expand access to innovative medicines by reducing delays, lowering costs, and strengthening supply security. 👉 medicinespatentpool.org/news-publica...

We’re thrilled to announce that the dedicated mRNA Technology Transfer Programme page on LinkedIn is live, the global initiative focused on improving health equity by building sustainable mRNA vaccine manufacturing capabilities in LMICs! 🔗 Follow the page: lnkd.in/dpKuv5b5 👉 www.mrnaProgramme.org

We’re proud to be recognized in the 2025 Global Health 50/50 Report as a high performer! MPP’s new Menstrual & Menopause Policy supports women’s health needs through flexible work, awareness & training. Read more: global5050.org/2025-report/

Proud to partner with @unitaid.bsky.social to help ensure health innovations reach those who need them most. At MPP, we contribute to expanding access to innovative medicines and other health technologies through public health‑oriented voluntary licensing and technology transfer. Have a read👇

MPP's Mila Maistat delivered a statement at the 6th meeting of the Intergovernmental Working Group on the @who.int #PandemicAgreement, highlighting the crucial role of non‑exclusive licensing and technology transfer for equitable pandemic preparedness. 🔗 medicinespatentpool.org/news-publica...

✨ Advancing access, Together ✨ We’re working to ensure people, especially in LMICs, can access innovative, effective, and affordable medicines and health technologies. Through collaboration, licensing, and tech transfer, we’re helping make equitable healthcare a global reality.💙 👉 lnkd.in/dJvmU_V

MPP's Mila Maistat helped launch the @who.int HBV & HCV Guidance, stressing that #viralhepatitis, #diagnostics, and affordable treatments via @medicinespatentpool.org #licensing are vital.

Recently LAPaL updates New drug delivery technologies: Multi-Arm Polymer Conjugated Immunotherapies Plexis Long-acting Injectable Technology New drugs: GS-3242 Acoziborole And we've updated: Ulonivirine VH-499 VH-148 Alimatravir GS-3107 www.liverpool.ac.uk/celt-global-... @medicinespatentpool.org

✨ Turning innovation into access ✨ 🌍 By working in #partnership with civil society, industry, governments and global health actors, MPP turns innovation into #affordable access to medicines in LMICs, because where you live should never define your access to care.💙 👉 medicinespatentpool.org

Today is the #IDMHR2026 🤰🌍, a reminder that too many women still die from childbirth complications. Midwife Mame Laitite Diallo Diouf 🇸🇳 shares how greater access to HSC could save lives. Our agreement with Ferring regarding HSC: https://medicinespatentpool.org/licence-post/heat-stable-carbetocin

🎥 Ahead of #WorldIntellectualPropertyDay, we’re pleased to launch Tutorial #3, spotlighting the advanced filters in #MedsPaL 🌍💊 👉 Check out the tutorial: www.youtube.com/watch?v=oEh-... 👉 Check out our video #tutorial series: www.youtube.com/playlist?lis... 🔗 www.medspal.org #WorldIPDay

🦟 #Malaria is preventable and curable, yet it continues to take hundreds of thousands of lives every year, mostly in LMICs. 🌍 Ahead of #WorldMalariaDay, MPP reaffirms its commitment to supporting access to life-saving malaria prevention and treatment tools. 👉 medicinespatentpool.org

At #WHA79, MPP highlighted the role of non-exclusive licensing and technology transfer in advancing the equity objectives of the @who.int Pandemic Agreement. medicinespatentpool.org/news-publica... #GlobalHealth #PandemicPreparedness #HealthEquity

🌍 World #Hepatitis Summit 2026 Today at #WHS2026, Charles Gore challenged how we frame the hepatitis #elimination debate: “If you ask ‘Can we achieve elimination?’ you mainly see the problems. If you ask ‘How do we achieve elimination?’ you start seeing the solutions.” @worldhepalliance.bsky.social

LAPaL updates: New drugs (full pharmacological data): - Benzathine benzylpenicillin LA compounds + regulatory info - Depulfavirine nanosphere LAI + clinical trial - Bictegravir PLGA nanoformulation + preclinical Updated: - Risperidone LAI - regulatory status www.liverpool.ac.uk/celt-global-...

🌍 At the #AfricaForward, MPP joined the panel “Health & Pharma: Building Competitive #African #Pharmaceutical Capacity.” 💬 The discussion highlighted key drivers of Africa’s pharmaceutical ecosystem: regulation, predictable markets, local production, technology transfer, and regional partnerships.

🌍 During the 79th #WHA79 in Geneva, MPP will engage both in the formal proceedings of the Assembly and in a number of side events and partner-led discussions. 📍See the full programme: medicinespatentpool.org/news-publica...

🚨 BREAKING: MPP today launches ambitious five-year strategy to further catalyse access to essential health products and technologies in low- and middle-income countries (LMICs). Read more about MPP's Strategy 2026-2030: https://medicinespatentpool.org/who-we-are/strategy

We’ve seen what #PublicHealth-oriented voluntary licensing + generic competition can do: TLD now supplied in 123 countries, reaching 24M users (2025), with a Global Fund 2026 price <US$35/year. The question: how do we replicate that pace for newer @who.int-recommended options? #INTEREST2026

Today at #WHA79, MPP and Roche celebrated the signing of a public health-oriented voluntary licence agreement for baloxavir marboxil, an #influenza antiviral treatment recommended by @who.int. Read the announcement: bit.ly/4wwZsW1 @unitaid.bsky.social @drduneton.bsky.social

Key takeaway from @sebmoringva.bsky.social at #INTEREST2026: newer regimens are already possible in generics. Uptake is still embryonic but with better alignment and reduced market fragmentation, there’s clear potential to unlock economies of scale, even in a tight financing context.

At #INTEREST2026 in Dar es Salaam earlier this week, @sebmoringva.bsky.social (MPP) unpacked what the new @who.int HIV treatment recommendations mean in practice: TAF-based regimens, DTG+3TC simplification, and long-acting CAB+RPV, and how access could be enhanced in many settings. #HIV

Join me tomorrow to explore #access opportunities for newly @who.int recommended non-TLD #HIV #treatment regimens - This is happening in Dar es Salaam - #Tanzania 🇹🇿

🚨 #AFRAVIH2026 – Retrouvez-nous à Lausanne ! 🇨🇭 📍 Stand 6 – Aujourd’hui et demain 👉 Échangez avec nos experts et découvrez nos actions pour améliorer l’accès aux traitements. 👉 medicinespatentpool.org/fr/news-publ... @sebmoringva.bsky.social

Nos collègues chez @unitaid.bsky.social ont raison : "L'accès ne s'improvise pas." On en parlera justement à #AFRAVIH à #Lausanne aujourd'hui ! --- #Équité #SantéPublique #SantéGlobale #AFRAVIH2026 #Francophonie

On se retrouve à #Lausanne la semaine prochaine pour parler de #VIH à l' #AFRAVIH2026 !

Useful strategic information #tools for anyone working on access to medicines in low- and middle-income countries. #AccessToMedicines #LMICs #Equity #GlobalHealth

Ahead of #WHS2026, Charles Gore spoke at the @who.int Global Forum on viral #hepatitis elimination, warning that HBV deaths are rising, treatment gaps persist, and advocacy still lags. #CHAI stressed that strong partnerships and urgent scale-up of diagnosis and treatment are key to elimination.

We’re always happy to show people how #MedsPaL – and our other #access to #medicines’ #tools – can be most effective, so do please contact us at: [email protected]

It's essential to embed #access thinking early while developing #technologies that may shape the future of #TB #prevention ! @medicinespatentpool.org is proud to be part of this partnership !

🚀 2 days away - 26 March | 14:00 CET ⏳ There’s still time to join the @medicinespatentpool.org for a 90-minute dedicated information session on our Strategy 2026–2030. Learn about our five-year goals and join a panel discussion on our strategic priorities. us06web.zoom.us/webinar/regi...

Expanding #PrEP access means meeting people where they are. Join #TheChoiceAgenda to hear how community health workers & pharmacists are taking #injectablePrEP beyond clinics and into homes, streets & communities. Register: avac-org.zoom.us/meeting/regi...

This #WorldTBDay, we spotlight long-acting injectables for latent TB - a single injection instead of months of pills. Through the LONGEVITY project, MPP’s partnership with Tandem Nano aims to simplify treatment, reduce stigma, and improve adherence. 👉 medicinespatentpool.org/story-post/l...

#WorldTBDay highlights that TB is preventable and curable, yet still kills over a million people yearly, with drug-resistant TB on the rise. Progress continues, but targets remain unmet. MPP helps expand access to treatments and accelerate new therapies. 👉 medicinespatentpool.org/progress-ach...

🌍 Marking #WorldTBDay with global collaboration! MPP highlights a meaningful meeting in Hanoi 🇻🇳 with Oanh Khuat (SCDI Vietnam), recently honored with France’s National Medal of Merit for her work supporting vulnerable communities and advancing HIV/AIDS and health policy. 🎦 youtu.be/ZtSwb-FsRCQ?...

✨ New logo reveal ✨ Since 2010, MPP has worked to expand #access to essential medicines and health technologies worldwide. A new look, the same unwavering commitment to equity and partnership. 👉 medicinespatentpool.org/news-publica... @unitaid.bsky.social

New health products only save lives if they reach those who need them. In @plosglobalpublichealth.org, Unitaid’s Janet Ginnard and co-authors examine how market shaping expanded access to HIV, TB, malaria, hep. C and Ebola products. ⬇️ journals.plos.org/globalpublic... cc. @medicinespatentpool.org

We’re excited to welcome Fitsum Alemayehu to the MPP’s Community Advisory Panel! He will bring his expertise in #pandemicpreparedness and community engagement to help ensure community perspectives guide our work for equitable access to health technologies. 👉 medicinespatentpool.org/who-we-are/g...

LAPaL provides long-acting medicinal product and drug delivery technology data Recently added: Risperidone LAI PGT-121 PGT-121.144.LS TLC ART combination therapy PGT-121.144.LS + VRC07-523LS Rifapentine Gemcitabine intravesical LAI system www.liverpool.ac.uk/celt-global-... @medicinespatentpool.org

📍 158th @who.int Executive Board As discussions on health emergencies and #pandemicpreparedness continue, the @medicinespatentpool.org highlighted critical gaps in the production of essential #vaccines and health technologies. 👉 medicinespatentpool.org/news-publica...

#IDWGS2026 👩‍⚕️🧪“𝑨𝒔 𝒂 𝒅𝒐𝒄𝒕𝒐𝒓, 𝒚𝒐𝒖 𝒎𝒂𝒚 𝒔𝒂𝒗𝒆 𝒐𝒏𝒆 𝒑𝒆𝒓𝒔𝒐𝒏 𝒂𝒕 𝒂 𝒕𝒊𝒎𝒆. 𝑩𝒖𝒕 𝒘𝒉𝒆𝒏 𝒚𝒐𝒖 𝒄𝒓𝒆𝒂𝒕𝒆 𝒂 𝒗𝒂𝒄𝒄𝒊𝒏𝒆, 𝒚𝒐𝒖 𝒄𝒂𝒏 𝒔𝒂𝒗𝒆 𝒂𝒏 𝒆𝒏𝒕𝒊𝒓𝒆 𝒄𝒐𝒎𝒎𝒖𝒏𝒊𝒕𝒚.” Huong Ngo Thu, 𝐏𝐨𝐥𝐲𝐯𝐚𝐜, 🇻🇳 www.youtube.com/watch?v=HVNK...

We have tools to #prevent #RSV complications in #infants; let's make these #available #globally! -- #MaternalVaccine #MonoclonalAntibody #Access #Equity #Affordability #Health

Meeting the UNAIDS 2030 targets could prevent 3.3 million new #HIV infections by 2030. 🌍 This depends on timely, affordable, and sustainable access across markets, and public health–oriented #voluntarylicensing is a proven way to help achieve it. 👉 https://medicinespatentpool.org/#HIV#voluntarylicensing#CROI2026

Advances in cardiometabolic health bring hope for #obesity and type 2 diabetes, but access gaps remain 🌍 At MPP, we promote equitable #access through #voluntary #licensing. On #WorldObesityDay 🌱, we stand for healthier lives ❤️ 👉 www.worldobesityday.org #WOD2026 @worldobesity.bsky.social

For #WorldObesityDay, Nomathemba Chandiwana of the Desmond Tutu Health Foundation calls for action on barriers to care. #Obesity is rising worldwide 🌍, and the World Obesity Federation urges an end to stigma and equitable access to care ✨. 👉 medicinespatentpool.org/story-post/w...